|
Market Closed -
CBOE
11:30:00 2026-09-21 EDT
|
After hours 16:00:01 | |||
| 131.66 EUR | +2.36% |
|
131.35 | -0.24% |
| 09-18 | Dr. Reddy's Confirms License for Gilead's Yearly-Once HIV Drug; Shares Up 2% | MT |
| 09-16 | Gilead Sciences Insider Sold Shares Worth $432,646, According to a Recent SEC Filing | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| GILEAD SCIENCES, INC. | Other Pharmaceuticals | +2.36% | -0.29% | - | - | - | 186B |
-
|
-
|
-
|
- Stock Market
- Stocks
- GILD Stock
- Stock
- Charts Gilead Sciences, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
